Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Oxford Immunotec (OXFD)

Oxford Immunotec (OXFD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 570,904
  • Shares Outstanding, K 25,962
  • Annual Sales, $ 73,710 K
  • Annual Income, $ -1,810 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta 1.38
  • Price/Sales 10.01
  • Price/Cash Flow 1,408.14
  • Price/Book 2.98
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.64
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 03/15/21
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/20
See More
  • Average Estimate -0.01
  • Number of Estimates 2
  • High Estimate 0.00
  • Low Estimate -0.02
  • Prior Year -0.06
  • Growth Rate Est. (year over year) +83.33%

Price Performance

See More
Period Period Low Period High Performance
1-Month
21.84 +0.69%
on 02/22/21
22.02 -0.14%
on 02/11/21
+0.01 (+0.05%)
since 02/05/21
3-Month
14.82 +48.38%
on 12/07/20
23.11 -4.84%
on 01/11/21
+6.68 (+43.63%)
since 12/04/20
52-Week
8.37 +162.72%
on 03/18/20
23.11 -4.84%
on 01/11/21
+8.65 (+64.84%)
since 03/05/20

Most Recent Stories

More News
Lifshitz Law Firm, P.C. Announces Investigation of CHNG, MGLN, OBLN, and OXFD

NEW YORK, NY / ACCESSWIRE / February 14, 2021 /Lifshitz Law Firm, P.C.: Change Healthcare Inc. (NASDAQ:CHNG) Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in...

CHNG : 27.49 (+0.26%)
MGLN : 94.99 (unch)
OBLN : 9.15 (-5.86%)
OXFD : 21.99 (+0.05%)
Oxford Immunotec Enters a Memorandum of Understanding (MOU) with GC MS (Green Cross Medical Science Corp. – South Korea) to Market the T-SPOT® Discovery SARS-CoV-2 Kit, for the Measurement of the T Cell Immune Response to SARS-CoV-2 Infection, in South

OXFORD, United Kingdom and MARLBOROUGH, Mass., Feb. 08, 2021 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq: OXFD) (the “Company”), a global, high-growth diagnostics company today announces...

OXFD : 21.99 (+0.05%)
Oxford Immunotec Updates Their T-SPOT® Discovery SARS-CoV-2 Kit and Include a New Panel to Detect T Cells Reactive to Endemic Coronaviruses

OXFORD, United Kingdom and MARLBOROUGH, Mass., Feb. 04, 2021 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq: OXFD) (the “Company”), a global, high-growth diagnostics company, today announces...

OXFD : 21.99 (+0.05%)
MERGER INVESTIGATION: Halper Sadeh LLP Investigates CMD, COHR, PS, OXFD; Shareholders Are Encouraged to Contact the Firm

NEW YORK, Jan. 21, 2021 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, continues to investigate the following companies:

CMD : 80.37 (-1.18%)
COHR : 92.11 (-0.18%)
PS : 22.45 (+0.13%)
OXFD : 21.99 (+0.05%)
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of Oxford Immunotec Global PLC Buyout

WILMINGTON, Del., Jan. 20, 2021 (GLOBE NEWSWIRE) -- Rigrodsky Law, P.A. announces that it is investigating Oxford Immunotec Global PLC (“Oxford Immunotec”) (NASDAQ GS: OXFD ) regarding possible...

OXFD : 21.99 (+0.05%)
PKI : 115.24 (-0.91%)
New Monthly Series Spotlights What 100 Physicians Find to be Critical Needs in Their Battle Against COVID-19

The first survey results reveal physicians seek new diagnostic tools and insights to improve COVID-19 management and patient outcomes

OXFD : 21.99 (+0.05%)
OXFORD IMMUNOTEC INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Oxford Immunotec Global PLC - OXFD

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Oxford Immunotec Global PLC (NasdaqGS: OXFD)...

OXFD : 21.99 (+0.05%)
PKI : 115.24 (-0.91%)
Oxford Immunotec’s T-SPOT® Discovery SARS-CoV-2 Test is Used to Measure the Efficacy of Valneva’s VLA2001 COVID-19 Vaccine Candidate in a Phase I/II Clinical Study

OXFORD, United Kingdom and MARLBOROUGH, Mass., Jan. 13, 2021 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq: OXFD) (the “Company”), a global, high-growth diagnostics company, announce the...

OXFD : 21.99 (+0.05%)
Oxford Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Oxford Immunotec Global PLC Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm – OXFD

Halper Sadeh LLP, a global investor rights law firm, is investigating whether Oxford Immunotec Global PLC (NASDAQ: OXFD) and its board of directors violated the federal securities laws and/or breached...

OXFD : 21.99 (+0.05%)
PerkinElmer to Acquire Oxford Immunotec Global PLC

PerkinElmer, Inc. (NYSE: PKI) (“ PerkinElmer ”) and Oxford Immunotec Global PLC (NASDAQ: OXFD) (" Oxford Immunotec " or the “ Company ”) are pleased to announce they have reached an agreement on...

PKI : 115.24 (-0.91%)
OXFD : 21.99 (+0.05%)

Business Summary

Oxford Immunotec Global PLC is a medical diagnostics company. It develops new tests for various diseases based on its, patented T cell measurement technology. The company's first product is the T-SPOT(R). Oxford Immunotec Global PLC is headquartered in Abingdon, the United Kingdom.

See More

Key Turning Points

3rd Resistance Point 22.02
2nd Resistance Point 22.00
1st Resistance Point 22.00
Last Price 21.99
1st Support Level 21.98
2nd Support Level 21.96
3rd Support Level 21.96

See More

52-Week High 23.11
Last Price 21.99
Fibonacci 61.8% 17.48
Fibonacci 50% 15.74
Fibonacci 38.2% 14.00
52-Week Low 8.37

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar